Список литературы

1. Дедов И.И. Сахарный диабет у детей и подростков/Дедов И.И., Кураева Т.Л., Петеркова В.А. - Москва: ГЭОТАР-Медиа, 2013. - 271 с.

2. Петеркова В.А. Особенности диабета типа 2 у детей и подростков/Петеркова В.А., Кураева Т.Л., Еремина И.А.//Сахарный диабет типа 2: от теории к практике. Под редакцией академика РАН И.И. Дедова, члена-корреспондента РАН М.В. Шестаковой. - Москва: ООО "Медицинское информационное агентство", 2016.

3. Studying progression from glucose intolerance to type 2 diabetes in obese children/I.A. Dubinina [et al.]//Diabetes & Metabolic Syndrome: Clinical Research & Reviews. - 2014. - Vol. 8. - N 3. - P. 133 - 137.

4. Проблемы диагностики и терапии сахарного диабета 2 типа у детей и подростков/Кураева Т.Л. [и др.]//Материалы V Городской научно-практической конференции "Эндокринологические аспекты в педиатрии". - Москва, 2011. - С. 26 - 33.

5. Дедов И.И. Эпидемиология сахарного диабета в Российской Федерации: клинико-статистический анализ по данным Федерального регистра сахарного диабета/И.И. Дедов, М.В. Шестакова, О.К. Викулова. - 2017. - Т. 1. - N 20. - С. 13 - 41.

6. Prevalence of Type 1 and Type 2 Diabetes Among Children and Adolescents From 2001 to 2009/D. Dabelea [et al.]//JAMA. - 2014. - Vol. 311. - N 17. - P. 1778.

7. Clinical polymorphism of type 2 diabetes in children - the first study in Russia/I.A. Eremina [и др.]//Problems of Endocrinology. - 2015. - Т. 61. - N 6. - С. 10 - 16.

8. ISPAD Clinical Practice Consensus Guidelines 2018: Definition, epidemiology, and classification of diabetes in children and adolescents/E.J. Mayer-Davis [et al.]//Pediatric Diabetes. - 2018. - Vol. 19. - P. 7 - 19.

9. Sabin, M.A. Type 2 diabetes in children: Type 2 diabetes in children/M.A. Sabin//Clinical Obesity. - 2013. - Vol. 3. - N 3 - 4. - P. 112 - 116.

10. World Health Organization. Definition and diagnosis of diabetes mellitus and intermediate hyperglycaemia: report of a WHO/IDF consultation/World Health Organization, International Diabetes Federation. - 2006.

11. The Presence of GAD and IA-2 Antibodies in Youth With a Type 2 Diabetes Phenotype: Results from the TODAY study/G.J. Klingensmith [et al.]//Diabetes Care. - 2010. - Vol. 33. - N 9. - P. 1970 - 1975.

12. ISPAD Clinical Practice Consensus Guidelines 2018: Type 2 diabetes mellitus in youth/P. Zeitler [et al.]//Pediatric Diabetes. - 2018. - Vol. 19. - P. 28 - 46.

13. HbA _1c After a Short Period of Monotherapy With Metformin Identifies Durable Glycemic Control Among Adolescents With Type 2 Diabetes/P. Zeitler [et al.]//Diabetes Care. - 2015. - Vol. 38. - N 12. - P. 2285 - 2292.

14. American Diabetes Association. 8. Pharmacologic Approaches to Glycemic Treatment: Standards of Medical Care in Diabetes - 2018/American Diabetes Association//Diabetes Care. - 2018. - Vol. 41. - N Supplement 1. - P. S73 - S85.

15. Glycemic Control in Youth with Diabetes: The SEARCH for Diabetes in Youth Study/D.B. Petitti [et al.]//The Journal of Pediatrics. - 2009. - Vol. 155. - N 5. - P. 668 - 672.e3.

16. Еремина И.А. Метформин в лечении сахарного диабета 2-го типа у детей и подростков/Еремина И.А., Кураева Т.Л. - 2013. - N 1. - С. 8 - 13.

17. Effect of Metformin in Pediatric Patients With Type 2 Diabetes: A randomized controlled trial/K.L. Jones [et al.]//Diabetes Care. - 2002. - Vol. 25. - N 1. - P. 89 - 94.

18. A clinical trial to maintain glycemic control in youth with type 2 diabetes/TODAY Study Group [et al.]//The New England Journal of Medicine. - 2012. - T. 366. - N 24. - P. 2247 - 2256.

19. American Diabetes Association. 13. Children and Adolescents: Standards of Medical Care in Diabetes - 2019/American Diabetes Association//Diabetes Care. - 2019. - Vol. 42. - N Supplement 1. - P. S148 - S164.

20. Evaluation and Management of Youth-Onset Type 2 Diabetes: A Position Statement by the American Diabetes Association/S. Arslanian [et al.]//Diabetes Care. - 2018. - Vol. 41. - N 12. - P. 2648 - 2668.

21. Liraglutide in Children and Adolescents with Type 2 Diabetes/W.V. Tamborlane [et al.]//New England Journal of Medicine. - 2019. - Vol. 381. - N 7. - P. 637 - 646.

22. New Insulin Delivery Recommendations/A.H. Frid [et al.]//Mayo Clinic Proceedings. - 2016. - T. 91. - N 9. - P. 1231 - 1255.

23. Техника инъекций и инфузии при лечении сахарного диабета. Методическое руководство./Майоров А.Ю. [и др.]. - Москва: ООО "АРТИНФО", 2018. - 64 с.

24. ISPAD Clinical Practice Consensus Guidelines 2018: Nutritional management in children and adolescents with diabetes/C.E. Smart [et al.]//Pediatric Diabetes. - 2018. - Vol. 19. - P. 136 - 154.

25. American Diabetes Association. 4. Lifestyle Management: Standards of Medical Care in Diabetes - 2018/American Diabetes Association//Diabetes Care. - 2018. - Vol. 41. - N Supplement 1. - P. S38 - S50.

26. Barlow, S.E. Expert Committee Recommendations Regarding the Prevention, Assessment, and Treatment of Child and Adolescent Overweight and Obesity: Summary Report/S.E. Barlow//Pediatrics. - 2007. - Vol. 120. - N Supplement 4. - P. S164 - S192.

27. A Systematic Review and Meta-Analysis of the Effect of Lifestyle Modification on Metabolic Control in Overweight Children/A.S.-Y. Lien [et al.]//Evidence-Based Complementary and Alternative Medicine. - 2017. - Vol. 2017. - P. 1 - 12.

28. Dhuper, S. Managing Cardiovascular Risk in Overweight Children and Adolescents/S. Dhuper, S. Buddhe, S. Patel//Pediatric Drugs. - 2013. - Vol. 15. - N 3. - P. 181 - 190.

29. 2013 AHA/ACC/TOS Guideline for the Management of Overweight and Obesity in Adults: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and The Obesity Society/M.D. Jensen [et al.]//Circulation. - 2014. - Vol. 129. - N 25 suppl 2. - P. S102 - S138.

30. Availability and night-time use of electronic entertainment and communication devices are associated with short sleep duration and obesity among Canadian children: EECD use and obesity among children/H. Chahal [et al.]//Pediatric Obesity. - 2013. - Vol. 8. - N 1. - P. 42 - 51.

31. Lane, A. Screen Time Increases Risk of Overweight and Obesity in Active and Inactive 9-Year-Old Irish Children: A Cross Sectional Analysis/A. Lane, M. Harrison, N. Murphy//Journal of Physical Activity and Health. - 2014. - T. 11. - N 5. - С. 985 - 991.

32. ISPAD Clinical Practice Consensus Guidelines 2018: Exercise in children and adolescents with diabetes/P. Adolfsson [et al.]//Pediatric Diabetes. - 2018. - Vol. 19. - P. 205 - 226.

33. A Systematic Review of Interventions to Improve Diabetes Care in Socially Disadvantaged Populations/R.H. Glazier [et al.]//Diabetes Care. - 2006. - Vol. 29. - N 7. - P. 1675 - 1688.

34. Youth-Onset Type 2 Diabetes Consensus Report: Current Status, Challenges, and Priorities/K.J. Nadeau [et al.]//Diabetes Care. - 2016. - Vol. 39. - N 9. - P. 1635 - 1642.

35. Exaggerated Adrenarche and Hyperinsulinism in Adolescent Girls Born Small for Gestational Age/L. [et al.]//The Journal of Clinical Endocrinology & Metabolism. - 1999. - Vol. 84. - N 12. - P. 4739 - 4741.

36. Dabelea, D. Maternal Environment and the Transgenerational Cycle of Obesity and Diabetes/D. Dabelea, T. Crume//Diabetes. - 2011. - Vol. 60. - N 7. - P. 1849 - 1855.

37. Higher incidence of diabetic nephropathy in type 2 than in type 1 diabetes in early-onset diabetes in Japan/H. Yokoyama [et al.]//Kidney International. - 2000. - Vol. 58. - N 1. - P. 302 - 311.

38. Stevens, P.E. Evaluation and management of chronic kidney disease: synopsis of the kidney disease: improving global outcomes 2012 clinical practice guideline/P.E. Stevens, A. Levin, Kidney Disease: Improving Global Outcomes Chronic Kidney Disease Guideline Development Work Group Members//Annals of Internal Medicine. - 2013. - Т. 158. - N 11. - P. 825 - 830.

39. New equations to estimate GFR in children with CKD/G.J. Schwartz [et al.]//Journal of the American Society of Nephrology: JASN. - 2009. - Т. 20. - N 3. - P. 629 - 637.

40. Schwartz, G.J. Measurement and estimation of GFR in children and adolescents/G.J. Schwartz, D.F. Work//Clinical journal of the American Society of Nephrology: CJASN. - 2009. - Т. 4. - N 11. - P. 1832 - 1843.

41. Characteristics of Adolescents and Youth with Recent-Onset Type 2 Diabetes: The TODAY Cohort at Baseline/K.C. Copeland [et al.]//The Journal of Clinical Endocrinology & Metabolism. - 2011. - Vol. 96. - N 1. - P. 159 - 167.

42. TODAY Study Group. Rapid Rise in Hypertension and Nephropathy in Youth With Type 2 Diabetes: The TODAY clinical trial/TODAY Study Group//Diabetes Care. - 2013. - Vol. 36. - N 6. - P. 1735 - 1741.

43. The Effect of Angiotensin-Converting-Enzyme Inhibition on Diabetic Nephropathy/E.J. Lewis [et al.]//New England Journal of Medicine. - 1993. - Vol. 329. - N 20. - P. 1456 - 1462.

44. Effects of angiotensin converting enzyme inhibitors and angiotensin II receptor antagonists on mortality and renal outcomes in diabetic nephropathy: systematic review/G.F.M. Strippoli [et al.]//BMJ (Clinical research ed.). - 2004. - Т. 329. - N 7470. - P. 828.

45. Antihypertensive agents for preventing diabetic kidney disease/J. Lv [et al.]//Cochrane Database of Systematic Reviews. - 2012.

46. Antihypertensive agents for preventing diabetic kidney disease/G.F. Strippoli [et al.]//Cochrane Database of Systematic Reviews/ed. The Cochrane Collaboration. - Chichester, UK: John Wiley & Sons, Ltd, 2005. - P. CD004136.pub2.

47. Comparative effectiveness of renin-angiotensin system blockers and other antihypertensive drugs in patients with diabetes: systematic review and bayesian network meta-analysis/H.-Y. Wu [et al.]//BMJ. - 2013. - Vol. 347. - N oct 24 2. - P. f6008 - f6008.

48. The effect of captopril therapy on the degree of microalbuminuria in diabetic children and adolescents with incipient nephropath/L Barkai 1, A , I - Orv Hetil. - 1996 Nov 17; 137(46): 2565 - 8.

49. Dinneen, S.F. The Association of Microalbuminuria and Mortality in Non-Insulin-Dependent Diabetes Mellitus: A Systematic Overview of the Literature/S.F. Dinneen//Archives of Internal Medicine. - 1997. - Vol. 157. - N 13. - P. 1413.

50. American Diabetes Association. 10. Microvascular Complications and Foot Care: Standards of Medical Care in Diabetes - 2018/American Diabetes Association//Diabetes Care. - 2018. - Vol. 41. - N Supplement 1. - P. S105 - S118.

51. Timing Is Everything: Age of Onset Influences Long-Term Retinopathy Risk in Type 2 Diabetes, Independent of Traditional Risk Factors/J. Wong [et al.]//Diabetes Care. - 2008. - Vol. 31. - N 10. - P. 1985 - 1990.

52. Long-Term Complications and Mortality in Young-Onset Diabetes: Type 2 diabetes is more hazardous and lethal than type 1 diabetes/M.I. Constantino [et al.]//Diabetes Care. - 2013. - Vol. 36. - N 12. - P. 3863 - 3869.

53. ISPAD Clinical Practice Consensus Guidelines 2018: Microvascular and macrovascular complications in children and adolescents/K.C. Donaghue [et al.]//Pediatric Diabetes. - 2018. - Vol. 19. - P. 262 - 274.

54. Anti-vascular endothelial growth factor for proliferative diabetic retinopathy/M.J. Martinez-Zapata [et al.]//Cochrane Database of Systematic Reviews. - 2014.

55. Simunovic, M.P. ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR THERAPY FOR PROLIFERATIVE DIABETIC RETINOPATHY: A Systematic Review and Meta-Analysis/M.P. Simunovic, D.A.L. Maberley//Retina. - 2015. - Vol. 35. - N 10. - P. 1931 - 1942.

56. TODAY Study Group. Retinopathy in Youth With Type 2 Diabetes Participating in the TODAY Clinical Trial/TODAY Study Group//Diabetes Care. - 2013. - Vol. 36. - N 6. - P. 1772 - 1774.

57. Prevalence of cardiovascular disease risk factors in U.S. children and adolescents with diabetes: the SEARCH for diabetes in youth study/B.L. Rodriguez [et al.]//Diabetes Care. - 2006. - Т. 29. - N 8. - P. 1891 - 1896.

58. Кардиоваскулярная форма автономной нейропатии у подростков с сахарным диабетом 2 типа/И.А. Еремина [и др.]//Проблемы эндокринологии. - 2014. - Т. 60. - N 5. - С. 15 - 21.

59. Maffi, P. The Burden of Diabetes: Emerging Data/P. Maffi, A. Secchi//Developments in Ophthalmology/eds. F. Bandello [et al.]. - S. Karger AG, 2017. - Vol. 60. - P. 1 - 5.

60. Cardiovascular autonomic neuropathy in adolescents and young adults with type 1 and type 2 diabetes: The SEARCH for Diabetes in Youth Cohort Study/M. Jaiswal [et al.]//Pediatric Diabetes. - 2018.

61. Management of Newly Diagnosed Type 2 Diabetes Mellitus (T2DM) in Children and Adolescents/K.C. Copeland [et al.]//PEDIATRICS. - 2013. - Vol. 131. - N 2. - P. 364 - 382.

62. EXPERT PANEL ON INTEGRATED GUIDELINES FOR CARDIOVASCULAR HEALTH AND RISK REDUCTION IN CHILDREN AND ADOLESCENTS. Expert Panel on Integrated Guidelines for Cardiovascular Health and Risk Reduction in Children and Adolescents: Summary Report/EXPERT PANEL ON INTEGRATED GUIDELINES FOR CARDIOVASCULAR HEALTH AND RISK REDUCTION IN CHILDREN AND ADOLESCENTS//PEDIATRICS. - 2011. - Vol. 128. - N Supplement. - P. S213 - S256.

63. TODAY Study Group. Lipid and Inflammatory Cardiovascular Risk Worsens Over 3 Years in Youth With Type 2 Diabetes: The TODAY clinical trial/TODAY Study Group//Diabetes Care. - 2013. - Vol. 36. - N 6. - P. 1758 - 1764.

64. Batisky, D.L. What Is the Optimal First-Line Agent in Children Requiring Antihypertensive Medication?/D.L. Batisky//Current Hypertension Reports. - 2012. - Vol. 14. - N 6. - P. 603 - 607.

65. Blowey, D.L. Update on the Pharmacologic Treatment of Hypertension in Pediatrics: Update on Pharmacologic Treatment in Pediatrics/D.L. Blowey//The Journal of Clinical Hypertension. - 2012. - Vol. 14. - N 6. - P. 383 - 387.

66. Diagnosis and Treatment of Polycystic Ovary Syndrome: An Endocrine Society Clinical Practice Guideline/R.S. Legro [et al.]//The Journal of Clinical Endocrinology & Metabolism. - 2013. - Vol. 98. - N 12. - P. 4565 - 4592.

67. Prevalence of Prediabetes and Type 2 Diabetes in Children With Nonalcoholic Fatty Liver Disease/K.P. Newton [et al.]//JAMA Pediatrics. - 2016. - Vol. 170. - N 10. - P. e161971.

68. Nadeau, K.J. Type 2 Diabetes in Children is Frequently Associated with Elevated Alanine Aminotransferase:/K.J. Nadeau, G. Klingensmith, P. Zeitler//Journal of Pediatric Gastroenterology and Nutrition. - 2005. - Vol. 41. - N 1. - P. 94 - 98.

69. Sundaram, S.S. The metabolic syndrome and nonalcoholic fatty liver disease in children:/S.S. Sundaram, P. Zeitler, K. Nadeau//Current Opinion in Pediatrics. - 2009. - Vol. 21. - N 4. - P. 529 - 535.

70. Lifestyle intervention in obese children with non-alcoholic fatty liver disease: 2-year follow-up study/T. Reinehr [et al.]//Archives of Disease in Childhood. - 2009. - Vol. 94. - N 6. - P. 437 - 442.

71. Independent predictors of liver fibrosis in patients with nonalcoholic steatohepatitis/P. Angulo [et al.]//Hepatology. - 1999. - Vol. 30. - N 6. - P. 1356 - 1362.

72. Sleep-disordered breathing and type 2 diabetes/J.E. Shaw [et al.]//Diabetes Research and Clinical Practice. - 2008. - Vol. 81. - N 1. - P. 2 - 12.

73. Obstructive Sleep Apnea Among Obese Patients With Type 2 Diabetes/G.D. Foster [et al.]//Diabetes Care. - 2009. - Vol. 32. - N 6. - P. 1017 - 1019.

74. ISPAD Clinical Practice Consensus Guidelines 2018: Assessment and management of hypoglycemia in children and adolescents with diabetes/M.B. Abraham [et al.]//Pediatric Diabetes. - 2018. - Vol. 19. - P. 178 - 192.